Page last updated: 2024-08-25

clarithromycin and cem 101

clarithromycin has been researched along with cem 101 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Castanheira, M; Jones, RN; Woosley, LN1
Higuchi, K; Inoue, K; Kishimoto, H; Kiyomiya, K; Saito, N; Shirasaka, Y; Takada, T; Tomabechi, R; Watai, K1

Other Studies

2 other study(ies) available for clarithromycin and cem 101

ArticleYear
CEM-101 activity against Gram-positive organisms.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Clarithromycin; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Gentamicins; Gram-Positive Bacteria; Ketolides; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin

2010
Macrolide and Ketolide Antibiotics Inhibit the Cytotoxic Effect of Trastuzumab Emtansine in HER2-Positive Breast Cancer Cells: Implication of a Potential Drug-ADC Interaction in Cancer Chemotherapy.
    Molecular pharmaceutics, 2023, Dec-04, Volume: 20, Issue:12

    Topics: Ado-Trastuzumab Emtansine; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Azithromycin; Breast Neoplasms; Clarithromycin; Female; Humans; Immunoconjugates; Ketolides; Lysosomes; Maytansine; Receptor, ErbB-2; Trastuzumab

2023